2016
Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV
O'Donnell MR, Daftary A, Frick M, Hirsch-Moverman Y, Amico KR, Senthilingam M, Wolf A, Metcalfe JZ, Isaakidis P, Davis JL, Zelnick JR, Brust JC, Naidu N, Garretson M, Bangsberg DR, Padayatchi N, Friedland G. Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV. The International Journal Of Tuberculosis And Lung Disease 2016, 20: 430-434. PMID: 26970149, PMCID: PMC4863995, DOI: 10.5588/ijtld.15.0360.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusDrug-resistant TBMedication adherenceNational TB Control ProgrammeDrug-resistant tuberculosisTB control programsPatient-centered modelPatient-centered careNew antimycobacterial agentsUnderstanding of adherenceHealth care systemAdherence supportTB-HIVObserved therapyImmunodeficiency virusComprehensive careTreatment outcomesTreatment supportTuberculosis diagnosticsPatientsCare systemCareAntimycobacterial agentsTreatment deliveryAdherence
2007
Tuberculosis, drug resistance, and HIV/AIDS: A triple threat
Friedland G. Tuberculosis, drug resistance, and HIV/AIDS: A triple threat. Current Infectious Disease Reports 2007, 9: 252. PMID: 17430708, DOI: 10.1007/s11908-007-0039-7.Peer-Reviewed Original ResearchTB drug resistanceHIV/AIDSDrug-resistant tuberculosisDrug resistanceTB control programsRapid molecular diagnostic techniquesMultiple drug resistanceAvailable diagnostic technologiesMolecular diagnostic techniquesTB diagnosisWorldwide epidemicTreatment successTherapeutic strategiesTuberculosisTherapeutic agentsAIDSThird epidemicTreatmentDiagnosisDiagnostic techniquesControl programsDiagnostic technologiesEpidemicTriple threatUrgent need